Page 63 - GTM-3-3

Global Translational Medicine COVID-19 and acute kidney injury

This study has some limitations. The number of patients References
with AKI was small. In addition, most of the included 1. COVID-Coronavirus Statistics. Worldometer. Available from:
studies were conducted in China, so the findings of this https://www.worldometers.info/coronavirus [Last accessed
analysis may not be generalizable to other parts of the on 2023 Jun 08].
world. Clinical data on patients after discharge from the 2. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated
hospital were absent, preventing the evaluation of the long- with in-hospital death of patients with COVID-19. Kidney
term impact of COVID-19 on health. More studies are Int. 2020;97(5):829-838.
needed to better understand the risk of AKI and mortality
in COVID-19 patients. doi: 10.1016/j.kint.2020.03.005
3. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred
5. Conclusion reporting items for systematic reviews and meta-analyses:
The PRISMA statement. BMJ. 2009;339:b2535.
Based on the limited available data, severe AKI in COVID-
19 patients is a significant clinical predictor of poor doi: 10.1136/bmj.b2535
outcomes and is associated with high mortality. Further 4. MedCalc Software. MedCalc Statistical Software Version
studies are needed to understand the factors contributing 16.4.3. [Computer Software].
to worse outcomes among COVID-19 patients with 5. Lim JH, Park SH, Jeon Y, et al. Fatal outcomes of COVID-19
AKI. A better understanding of these factors could guide in patients with severe acute kidney injury. J Clin Med.
health-care providers in making more informed decisions 2020;9(6):1718.
regarding dialysis eligibility, especially when resources are doi: 10.3390/jcm9061718
limited.
6. Shao L, Li X, Zhou Y, et al. Novel insights into illness
Acknowledgments progression and risk profiles for mortality in non-survivors
of COVID-19. Front Med (Lausanne). 2020;7:246.
None. doi: 10.3389/fmed.2020.00246

Funding 7. Wang D, Yin Y, Hu C, et al. Clinical course and outcome
of 107 patients infected with the novel coronavirus, SARS-
None. CoV-2, discharged from two hospitals in Wuhan, China.
Crit Care. 2020;24(1):188.
Conflict of interest
doi: 10.1186/s13054-020-02895-6
The authors declare that they have no competing interests.
8. Li Z, Wu M, Yao J, et al. Caution on kidney dysfunctions of
Author contributions COVID-19 patients. Cold Spring Harbor Laboratory; 2020.
doi: 10.1101/2020.02.08.20021212
Conceptualization: Md. Safiullah Sarker, Rubiyat Jahan
Writing – original draft: Rubiyat Jahan 9. Zaki N, Mohamed EA. The estimations of the COVID-
Writing – review & editing: Md. Safiullah Sarker, Mohammed 19 incubation period: A scoping reviews of the literature.
Moshtaq Pervez J Infect Public Health. 2021;14(5):638-646.
doi: 10.1016/j.jiph.2021.01.019
Ethics approval and consent to participate
10. Collins S, Starkman E. Coronavirus Incubation Period.
Not applicable. Available from: https://www.webmd.com/covid/
coronavirus-incubation-period [Last accessed on
Consent for publication 2024 Jan 07].
Not applicable. 11. Marques F, Gameiro J, Oliveira J, et al. Acute kidney disease
and mortality in acute kidney injury patients with COVID-19.
Availability of data J Clin Med. 2021;10(19):4599.
doi: 10.3390/jcm10194599
Not applicable.
12. Patel SK, Singh R, Rana J, et al. The kidney and COVID-
Further disclosure 19 patients - important considerations. Travel Med Infect
Dis. 2020;37:101831.
The paper has been uploaded to or deposited in a preprint
server MedRxiv (https://submit.medrxiv.org/submission/ doi: 10.1016/j.tmaid.2020.101831
pdf?msid=MEDRXIV/2023/299310&roleName=author). 13. Bruggeman LA. Common mechanisms of viral injury to the

Volume 3 Issue 3 (2024) 10 doi: 10.36922/gtm.2798